Trademark: 86939190
Word
KYTEUVIA
Status
Dead
Status Code
710
Status Date
Friday, November 17, 2023
Serial Number
86939190
Registration Number
5194185
Registration Date
Tuesday, May 2, 2017
Mark Type
4000
Filing Date
Monday, March 14, 2016
Published for Opposition
Tuesday, February 14, 2017
Cancellation Date
Friday, November 17, 2023

Trademark Owner History
GW Research Limited - Original Registrant

Classifications
5 Pharmaceutical preparations and substances for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; pharmaceutical preparations and substances for the treatment of pediatric epilepsy; pharmaceutical preparations and substances for the treatment of Dravet syndrome, hypoxic-ischaemic encephalopathy, Lennox-Gastaut syndrome (LGS), tuberous sclerosis syndrome, intractable childhood epilepsy with generalized tonic-clonic seizures (ICE-GTC), generalized epilepsy with febrile seizures plus (GEFS+), dup 15q infantile spasms, and Doose syndrome; herbs for medicinal purposes; medicinal herbs; medicinal oils; medicinal infusions for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, bone disorders, hypoxic-ischaemic encephalopathy, drug, alcohol and nicotine abuse and inflammatory disorders; pure extracts of medicinal plants and herbs used for the treatment of epilepsy, convulsions, seizures, pain, multiple sclerosis, neuropathic pain, spinal cord injury, bladder disfunction, peripheral neuropathy, cancer pain, peri-operative pain, rheumatoid arthritis, inflammatory bowel disease, ulcerative colitis, neurogenic symptoms, psychotic disorders, diseases of the central nervous system, stroke and head injury, motion sickness and chemically induced sickness, spasticity, oncology, cancer symptoms, psychiatric illnesses, neurodegenerative diseases, metabolic disorders, obesity, obesity associated with type II diabetes, bulimia, schizophrenia, crohn's disease, alzheimer's, hypoxic-ischaemic encephalopathy, bone disorders, drug, alcohol and nicotine abuse and inflammatory disorders; herb teas for medicinal purposes

Trademark Events
Nov 17, 2023
Cancelled Sec. 8 (6-Yr)
May 2, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Sep 15, 2021
Teas Change Of Correspondence Received
Sep 15, 2021
Teas Change Of Domestic Representatives Address
Sep 15, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 15, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Jul 28, 2021
Assignment Of Ownership Not Updated Automatically
Nov 29, 2017
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 29, 2017
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 2, 2017
Registered-Principal Register
Feb 14, 2017
Official Gazette Publication Confirmation E-Mailed
Feb 14, 2017
Published For Opposition
Jan 25, 2017
Notification Of Notice Of Publication E-Mailed
Jan 10, 2017
Law Office Publication Review Completed
Jan 4, 2017
Approved For Pub - Principal Register
Jan 4, 2017
Examiner's Amendment Entered
Jan 4, 2017
Notification Of Examiners Amendment E-Mailed
Jan 4, 2017
Examiners Amendment E-Mailed
Jan 4, 2017
Examiners Amendment -Written
Dec 22, 2016
Teas/Email Correspondence Entered
Dec 22, 2016
Correspondence Received In Law Office
Dec 17, 2016
Assigned To Lie
Dec 4, 2016
Teas Response To Office Action Received
Jun 24, 2016
Notification Of Non-Final Action E-Mailed
Jun 24, 2016
Non-Final Action E-Mailed
Jun 24, 2016
Non-Final Action Written
Jun 24, 2016
Assigned To Examiner
Mar 17, 2016
New Application Office Supplied Data Entered
Mar 17, 2016
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24